Immix Biopharma, Inc. (IMMX) stock
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.20−0.28 (-3.74%)
Close on Nov 17, 2026Market cap $515.08MP/E –Yield –
Immix Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Immix Biopharma's price to book ratio was 2.7× on Nov 11, 2026, against 13.6× a year earlier. Over the last 5 years it ranged from 0.8× to 23.2×, with a median of 3.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.7× | −20.5 |
| 2025 | Oct 31, 2025 | 23.2× | +19.8 |
| 2024 | Dec 31, 2024 | 3.4× | −3.4 |
| 2023 | Dec 29, 2023 | 6.9× | +5.0 |
| 2022 | Dec 30, 2022 | 1.9× | – |
See a number that looks wrong?